The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Novel solutions to improve human health, born at Lund University. Explore LU Ventures' Life Science portfolio.

Explore the full Life Science Portfolio

  • Asgard Therapeutics - Direct cell reprogramming technologies for cancer immunotherapy.
  • Sinntaxis - Novel therapeutics to enhance recovery after stroke 
  • Abarceo - On a mission ​to reverse diabetes​
  • Apoglyx - New therapies ​for inflammatory diseases​
  • Mireca Medicine - Developing small molecules to treat a broad band of photoreceptor mutations.
  • Minervax - Developing a novel vaccine candidate against Group B Streptococci (GBS)
  • Strominnate Therapeutics - Aiming to treat diseases in the nervous system
  • Cell Invent - a new way to find Alzheimer’s cures

  • MedVasc - Novel instrument for a less painful and more cost-effective treatment of varicose veins
  • UmanSense - Develops a stroke alarm that notifies relatives in case of a suspected stroke
  • Suturion - Develops an instrument for suturing the abdominal wall after surgery
  • Medbeat - Mobile ECG module for arrhythmia detection.
  • Gedea Biotech - antibiotic-free treatment of bacterial vaginosis 
  • Stairway Medical - Medical device for open airway during sedation.
  • CarpoNovum - a new generation of surgical instruments, used throughout cancer surgery in the colon and rectum. 

  • Trackpaw Scientific - Introducing a new way of monitoring preclinical studies
  • Bionamic - Software for managing the process of biologic drug development.
  • Saromics Biostructures - a new technique for testing pharmaceutical substances using 3D structure analysis.

Curious to invest or get involved?

Contact Christine Widstrand,
CEO LU Ventures

christine [dot] widstrand [at] innovation [dot] lu [dot] se (christine[dot]widstrand[at]innovation[dot]lu[dot]se)
+46 70 928 63 78